International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 738-742 doi: 10.5281/zenodo.16890537
Original Article
Placenta Accrete Spectrum-Fetomaternal Outcome In A Tertiary Care Hospital Of Assam
 ,
 ,
Published
Aug. 17, 2025
Abstract

Background: Placenta Accreta Spectrum (PAS) is a serious obstetrics condition in which the placenta abnormaly invades the uterine wall, extending partially or fully into the myometrium and sometimes up to the serosa. This abnormal implantation significantly increases the risk of complication for both the mother and the baby, including severe haemorrhage, the need for blood transfusion, and higher likelihood of requiring a hysterectomy at the time of delivery.

Objective: The objective of this study was to ascertain the clinical presentation and evaluate maternal and fetal outcome in cases of Placenta Accreta Spectrum managed at a tertiary care hospital.

Method: This prospective observational study included all patients presenting to the Antenatal Outpatient Department, Emergency Labour Room, High-Risk Pregnancy Room and Intensive care unit. Detailed history of current and previous pregnancies were recorded. Routine and general examinations were conducted and patient were followed until discharge.

Result: A total of 45 patient were diagnosed with PAS during this study period with an incidence of 0.28%. In the study incidence came out be 0.28%. Mean age of PAS was 30.6 +/-1.6. years. Major risk factors were placenta previa (80%) and history of previous LSCS (73.9%%) and Multiparity(93.3%). Among the three types( 55.6%) patients had placenta accrete,(15.6%)had placenta increta and (28.9%) patients had placenta percreta. Major maternal complications seen in cases of PAS were bladder injury (6.7%). Intraoperative blood loss more than 1.5L was seen in (55.6%) and 2 patients required more than 5 units of Blood Transfusion. There was no mortality rate. Requirement of caesarean hysterectomy was seen in 33.3% cases. Pre-term delivery was seen in 66.7%, low birth weight was seen in 53.3% of the cases, NICU admission was seen in 24.4%.

Conclusion: Accurate prenatal diagnosis of PAS allows for timely planning by a multidisciplinary team, significantly reducing the risk of surgical complications, maternal blood loss, and prolonged ICU stays. Early detection and comprehensive care are crucial to improve both maternal and fetal outcome in pregnancies complicated by PAS.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
677 Views
180 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved